Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $732 billion, has been ...

Erste Group upgraded Eli Lilly (LLY) to Buy from Hold. Eli Lilly has products that are in high demand as well as “an extensive pipeline of ...

Erste Group analysts upgraded Eli Lilly stock from Hold to Buy, citing a robust product demand and a promising pipeline of potential successes. The analysts highlighted the pharmaceutical company's ...

Eli Lilly said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound.

With the recent $1.8 billion manufacturing investment in Ireland and the $4.5 billion investment in the Lilly Medicine Foundry in Indiana, it evidences the strong demand for its products.

The company would likely see the demand for Mounjaro and Zepbound increase, especially if insurers begin directing their members to Lilly's products to lower their costs. So, will Trump make Lilly ...

The plant will be used to "support increased demand for existing Lilly products and play a key role in bringing Lilly's robust clinical pipeline…to patients around the world," said the IDA ...

The Tempo pen is currently compatible with three of Lilly's insulin products, including Humalog and Lyumjev, both insulin lispro-based, and insulin glargine brand Basaglar. "Despite technological ...

While this may be a favorable result for Lilly, its lawsuit against FDA is a sign that it never wants to go through a similar exercise again. No. Biological products are not eligible for the ...

Similar to third-quarter 2024, management stated that sales of both Mounjaro and Zepbound were hurt by lower-than-expected channel inventory of the products. Eli Lilly is scheduled to report ...

Lilly Pulitzer (3) If you’ve been looking for an opportunity to add some color to your wardrobe, the wait is over: Lilly Pulitzer’s Sunshine Sale is here, and it’s brimming with vibrant ...